title: Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products.
authors.affiliation: Department of Internal Medicine II-Cardiology, University of Ulm, Robert-Koch-Str. 8, D-89081 Ulm, Germany. nikolaus.marx@medizin.uni-ulm.de
authors.forename: Nikolaus
authors.initials: N
authors.lastname: Marx
authors.forename: Daniel
authors.initials: D
authors.lastname: Walcher
authors.forename: Nina
authors.initials: N
authors.lastname: Ivanova
authors.forename: Kirstin
authors.initials: K
authors.lastname: Rautzenberg
authors.forename: Annelie
authors.initials: A
authors.lastname: Jung
authors.forename: Reinhard
authors.initials: R
authors.lastname: Friedl
authors.forename: Vinzenz
authors.initials: V
authors.lastname: Hombach
authors.forename: Raffaele
authors.initials: R
authors.lastname: de Caterina
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Basta
authors.forename: Marie-Paule
authors.initials: MP
authors.lastname: Wautier
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Wautiers
mesh_terms: D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D016328:NF-kappa B / Q000378:metabolism; D000077205:Pioglitazone; D011401:Promoter Regions, Genetic / Q000187:drug effects / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic / Q000187:drug effects / Q000235:genetics*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000494:pharmacology*; D014158:Transcription, Genetic / Q000187:drug effects*; D014471:Umbilical Veins
chemical_list: D007004:Hypoglycemic Agents; D016328:NF-kappa B; D012333:RNA, Messenger; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D000077205:Pioglitazone